Ambu A/S AMBU-B.CO
Nasdaq Copenhagen · Healthcare · Medical Devices
87.60 DKK
−2.2%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Ambu
| DKK million | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 4,013 | 4,444 | 4,775 | 5,391 |
| EBITDA | 550 | 492 | 619 | 1,023 |
| Net income | 247 | 93 | 168 | 235 |
| Balance sheet | ||||
| Equity | 3,952 | 4,261 | 5,393 | 5,594 |
| Total debt | 823 | 1,845 | 584 | 558 |
| Cash | 64 | 187 | 157 | 615 |
| Net debt | 759 | 1,658 | 427 | −57 |
| Ratios and per share | ||||
| EBITDA margin | 13.7% | 11.1% | 13.0% | 19.0% |
| Profit margin | 6.2% | 2.1% | 3.5% | 4.4% |
| Return on equity | 6.2% | 2.2% | 3.1% | 4.2% |
| Earnings/share (DKK) | 0.97 | 0.37 | 0.63 | 0.88 |
| Book value/share (DKK) | 15.58 | 16.77 | 20.25 | 21.00 |
| Shares outstanding (M) | 254 | 254 | 266 | 266 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | – |
| P/B | – |
| EV / EBITDA | – |
| Net debt / EBITDA | – |
| Return on equity | – |
| Profit margin | – |
| Beta 1Y | 0.77 |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (DKK)
| 2025 | 0.41 |
| 2024 | 0.38 |
| 2021 | 0.29 |
Not investment advice. Figures may contain errors from the data source.